J. Rosa

1.9k total citations
50 papers, 832 citations indexed

About

J. Rosa is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, J. Rosa has authored 50 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Cardiology and Cardiovascular Medicine and 21 papers in Surgery. Recurrent topics in J. Rosa's work include Hormonal Regulation and Hypertension (26 papers), Blood Pressure and Hypertension Studies (22 papers) and Adrenal and Paraganglionic Tumors (16 papers). J. Rosa is often cited by papers focused on Hormonal Regulation and Hypertension (26 papers), Blood Pressure and Hypertension Studies (22 papers) and Adrenal and Paraganglionic Tumors (16 papers). J. Rosa collaborates with scholars based in Czechia, United States and United Kingdom. J. Rosa's co-authors include J Widimský, Ondřej Petrák, Robert Holaj, Branislav Štrauch, Tomáš Zelinka, Dan Wichterle, Zuzana Šomlóová, Tomáš Indra, David Michalský and M Kasalický and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Hypertension and European Heart Journal.

In The Last Decade

J. Rosa

46 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Rosa Czechia 17 491 472 380 96 63 50 832
Ondřej Petrák Czechia 20 833 1.7× 590 1.3× 707 1.9× 107 1.1× 65 1.0× 65 1.3k
Enrico Agabiti Rosei Italy 19 290 0.6× 724 1.5× 178 0.5× 178 1.9× 14 0.2× 32 994
Amy I. Lynch United States 16 184 0.4× 536 1.1× 125 0.3× 44 0.5× 11 0.2× 29 808
Diane Cowley Australia 10 732 1.5× 592 1.3× 603 1.6× 95 1.0× 9 0.1× 16 1.2k
Magdi Ghali United States 8 172 0.4× 828 1.8× 462 1.2× 64 0.7× 11 0.2× 17 1.1k
B Severgnini Italy 16 235 0.5× 962 2.0× 183 0.5× 140 1.5× 21 0.3× 30 1.2k
Karpov IuA Russia 12 168 0.3× 466 1.0× 160 0.4× 47 0.5× 20 0.3× 141 723
Annemarie M.J. Wassink Netherlands 14 187 0.4× 294 0.6× 171 0.5× 18 0.2× 15 0.2× 18 686
Peter Held Sweden 18 277 0.6× 1.5k 3.2× 424 1.1× 21 0.2× 24 0.4× 35 1.7k
S. T. Turner United States 15 156 0.3× 247 0.5× 222 0.6× 54 0.6× 6 0.1× 18 626

Countries citing papers authored by J. Rosa

Since Specialization
Citations

This map shows the geographic impact of J. Rosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Rosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Rosa more than expected).

Fields of papers citing papers by J. Rosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Rosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Rosa. The network helps show where J. Rosa may publish in the future.

Co-authorship network of co-authors of J. Rosa

This figure shows the co-authorship network connecting the top 25 collaborators of J. Rosa. A scholar is included among the top collaborators of J. Rosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Rosa. J. Rosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seefried, Lothar, Serge Ferrari, Ombretta Viapiana, et al.. (2025). A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis. Osteoporosis International. 36(12). 2497–2507. 1 indexed citations
2.
Chung, Yoon‐Sok, Bente Langdahl, E. J. Czerwiński, et al.. (2024). SB16 versus reference denosumab in postmenopausal women with osteoporosis: 18-month outcomes of a phase III randomized clinical trial. Bone. 192. 117371–117371. 1 indexed citations
3.
Langdahl, Bente, Yoon‐Sok Chung, E. J. Czerwiński, et al.. (2024). Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12. The Journal of Clinical Endocrinology & Metabolism. 110(6). e1951–e1958. 4 indexed citations
4.
Zelinka, Tomáš, Ondřej Petrák, J. Rosa, et al.. (2020). Primary Aldosteronism and Pregnancy. Kidney & Blood Pressure Research. 45(2). 275–285. 9 indexed citations
5.
Štěpán, J, J. Rosa, & Karel Pavelká. (2016). [Raloxifene - an unexploited possibility of prevention and treatment of postmenopausal osteoporosis].. PubMed. 62(10). 781–788. 1 indexed citations
6.
Rosa, J., Petr Waldauf, Lukáš Lambert, et al.. (2016). [OP.7D.09] THE ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN TRUE RESISTANT HYPERTENSION. ONE-YEAR OUTCOMES OF RANDOMIZED PRAGUE-15 STUDY. Journal of Hypertension. 34(Supplement 2). e96–e97. 1 indexed citations
7.
Jin, Yu, Anne Cecilie K. Larstorp, Alexandre Persu, et al.. (2015). Renal sympathetic denervation in patients with treatment resistant hypertension: a meta-analysis of randomized controlled trials. European Heart Journal. 36. 185–185. 1 indexed citations
8.
Elmula, Fadl Elmula M. Fadl, Yu Jin, Wen‐Yi Yang, et al.. (2015). Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Blood Pressure. 24(5). 263–274. 46 indexed citations
9.
Persu, Alexandre, Michel Azizi, Yu Jin, et al.. (2014). Hyperresponders vs. nonresponder patients after renal denervation. Journal of Hypertension. 32(12). 2422–2427. 24 indexed citations
10.
Čurila, Karol, J. Rosa, Petr Toušek, J Widimský, & Petr Widimský. (2014). Technical and safety aspects of renal denervation. Cor et Vasa. 56(3). e228–e234. 1 indexed citations
11.
Rosa, J., Tomáš Zelinka, Ondřej Petrák, et al.. (2014). Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?. Journal of Human Hypertension. 28(11). 684–688. 16 indexed citations
12.
Štrauch, Branislav, Ondřej Petrák, Tomáš Zelinka, et al.. (2013). Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. Journal of Hypertension. 31(12). 2455–2461. 104 indexed citations
13.
Widimský, J, Branislav Štrauch, Ondřej Petrák, et al.. (2012). Vascular Disturbances in Primary Aldosteronism: Clinical Evidence. Kidney & Blood Pressure Research. 35(6). 529–533. 26 indexed citations
14.
Zelinka, Tomáš, M Kasalický, David Michalský, et al.. (2012). Discrepant Results of Adrenal Venous Sampling in Seven Patients with Primary Aldosteronism. Kidney & Blood Pressure Research. 35(4). 205–210. 17 indexed citations
15.
Štrauch, Branislav, Ivana Kurcová, Ondřej Petrák, et al.. (2011). How to assess non-compliance with the pharmacotherapy in severe resistant hypertension?. Cor et Vasa. 53(8-9). 429–432.
16.
Widimský, J, J. Rosa, Dan Wichterle, et al.. (2010). The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. Journal of Human Hypertension. 24(10). 625–630. 43 indexed citations
17.
Petrák, Ondřej, Branislav Štrauch, Tomáš Zelinka, et al.. (2010). Factors influencing arterial stiffness in pheochromocytoma and effect of adrenalectomy. Hypertension Research. 33(5). 454–459. 25 indexed citations
18.
Rosa, J., Ivan Raška, Dan Wichterle, et al.. (2010). Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy. Hypertension Research. 34(3). 296–300. 40 indexed citations
19.
Rosa, J., Branislav Štrauch, Ondřej Petrák, et al.. (2008). Relationship between clinical, 24-hour, average day-time and night-time blood pressure and measures of arterial stiffness in essential hypertension. Physiological Research. 57(2). 303–306. 3 indexed citations
20.
Štrauch, Branislav, Ondřej Petrák, Tomáš Zelinka, et al.. (2008). Adrenalectomy Improves Arterial Stiffness in Primary Aldosteronism. American Journal of Hypertension. 21(10). 1086–1092. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ondřej Petrák Breakdown of academic impact, for papers by Enrico Agabiti Rosei Breakdown of academic impact, for papers by Amy I. Lynch Breakdown of academic impact, for papers by Diane Cowley Breakdown of academic impact, for papers by Magdi Ghali Breakdown of academic impact, for papers by B Severgnini Breakdown of academic impact, for papers by Karpov IuA Breakdown of academic impact, for papers by Annemarie M.J. Wassink Breakdown of academic impact, for papers by Peter Held Breakdown of academic impact, for papers by S. T. Turner
Rankless by CCL
2026